NeurologyLive® Friday 5 — February 23, 2024

News
Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 23, 2024.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Recognizing and Addressing Comorbidities in Complex Headache Disorders: Svetlana Blitshteyn, MD, FAAN

The director of Dysautonomia Clinic talked about the importance of focusing beyond migraine to address often overlooked comorbidities such as dysautonomia, hypermobility spectrum disorders, and mast cell activation syndrome. [WATCH TIME: 10 minutes]

Recognizing and Addressing Comorbidities in Complex Headache Disorders: Svetlana Blitshteyn, MD, FAAN

2: New Directions and Practice Impacting Recommendations in Multiple Sclerosis

This publication presents a collection of insights and takeaways from presentations with the goal of bridging the gaps between new developments and their application in practice for multiple sclerosis.

New Directions and Practice Impacting Recommendations in Multiple Sclerosis

3: Highlights of ISC 2024, Trials and Future Innovations for Stroke Care: Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

The medical director of the Cooper Neurological Institute and the professor of neurology at Yale University School of Medicine shared a few highlights from research presented at ISC 2024. [WATCH TIME: 7 minutes]

 Highlights of ISC 2024, Trials and Future Innovations for Stroke Care: Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

4: NeuroVoices: Rita Sattler, MD, MSc, on 2024 MDA Conference and Advances in ALS Research

In this week's NeuroVoices Q&A, the professor in the Department of Translational Neuroscience at Barrow Neurological Institute discussed several topics related to ALS research and the emerging biomarkers in recent years ahead of the 2024 MDA Clinical and Scientific Conference.

 NeuroVoices: Rita Sattler, MD, MSc, on 2024 MDA Conference and Advances in ALS Research

5: Neurofilament Light Chain and MS Prognosis, Treatment Effect, and Anticipation of Disease

In a new episode of the "CMSC Consensus Panel Guidance on the Use of Serum Neurofilament Light Chain in the Management of Multiple Sclerosis" video series, Mark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, contextualize data from large studies regarding the utilization of neurofilament light chain.

Neurofilament Light Chain and MS Prognosis, Treatment Effect, and Anticipation of Disease
Related Videos
Kevin Church, PhD
Merit Cudkowicz, MD, MSc
Jessica Ailani, MD
Frederic Schaper, MD, PhD
Jaime Imitol, MD
© 2024 MJH Life Sciences

All rights reserved.